10,000 results · 48ms · Sources: EU EUDAMED, US FDA

Myosin heavy chain 11 (QR064)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

Myosin heavy chain 11 (QR064)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

Myosin heavy chain 11 (QR064)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

Myosin heavy chain 11 (QR064)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

Myogenin (QR089)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

Myogenin (QR089)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

Myogenin (QR089)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

Myogenin (QR089)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

Myogenin (QR089)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

Myogenin (QR089)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

Myogenin (QR089)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

MyoD1 (QR069)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

MyoD1 (QR069)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

MyoD1 (QR069)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

MyoD1 (QR069)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

MyoD1 (QR069)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

MyoD1 (QR069)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

MyoD1 (QR069)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

MUM1 (QR075)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market

MUM1 (QR075)

Device
EU IVDD · Eu Ivd General ·biocyc Biotechnologie GmbH & Co. KG·On the market